C07D 217/24
Oxygen atoms
C07D217/24 (Oxygen atoms) appears on 704 US grants and 646 published applications in this corpus.
Search patents in C07D- Granted patents
- 704
- Published applications
- 646
- Assignees
- 396
- Inventors
- 2,424
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 16 | 0 |
| 1978 | 18 | 0 |
| 1979 | 10 | 0 |
| 1980 | 7 | 0 |
| 1981 | 8 | 0 |
| 1982 | 10 | 0 |
| 1983 | 8 | 0 |
| 1984 | 5 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 11 | 0 |
| 1988 | 8 | 0 |
| 1989 | 9 | 0 |
| 1990 | 5 | 0 |
| 1991 | 5 | 0 |
| 1992 | 6 | 0 |
| 1993 | 8 | 0 |
| 1994 | 9 | 0 |
| 1995 | 8 | 0 |
| 1996 | 18 | 0 |
| 1997 | 14 | 0 |
| 1998 | 12 | 0 |
| 1999 | 2 | 0 |
| 2000 | 11 | 0 |
| 2001 | 11 | 1 |
| 2002 | 14 | 18 |
| 2003 | 12 | 17 |
| 2004 | 10 | 35 |
| 2005 | 8 | 23 |
| 2006 | 12 | 22 |
| 2007 | 12 | 27 |
| 2008 | 22 | 30 |
| 2009 | 9 | 21 |
| 2010 | 21 | 37 |
| 2011 | 26 | 30 |
| 2012 | 25 | 27 |
| 2013 | 30 | 37 |
| 2014 | 36 | 29 |
| 2015 | 26 | 27 |
| 2016 | 19 | 29 |
| 2017 | 23 | 26 |
| 2018 | 20 | 30 |
| 2019 | 22 | 19 |
| 2020 | 26 | 25 |
| 2021 | 22 | 26 |
| 2022 | 12 | 19 |
| 2023 | 21 | 34 |
| 2024 | 11 | 22 |
| 2025 | 13 | 16 |
| 2026 | 14 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Process for the preparation of bromodomain inhibitor8 Sep 2026US 12,729,183 B2Celgene Quanticel Research, Inc.
- 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)23 Jun 2026US 12,662,471 B2Vertex Pharmaceuticals Incorporated
- MRGPRX2 antagonist for the treatment of pseudo allergic reactions2 Jun 2026US 12,642,795 B2The University of Hong Kong
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Isoquinoline derivatives for use as antiviral and antitumour agents19 May 2026US 12,630,523 B2Pags Co., Ltd.
- Bicyclic compounds8 Oct 2026US 2026/0308114 A1Vivace Therapeutics, Inc.
- A method for synthesizing aryl ethers ortho-substituted to the nitrogen atom of n-heterocycles3 Sep 2026US 2026/0257997 A1Xinjiang University
- Process for the preparation of (6s,9r)-3-oxo-3,5,6,7,8,9-hexahydro-2h-6,9-epiminocyclohepta[c]pyridazine-10-carboxamide derivatives3 Sep 2026US 2026/0258043 A1Pathios Therapeutics Limited
- Heterocyclic compounds as pi3ka inhibitors6 Aug 2026US 2026/0226010 A1Pikavation Therapeutics, Inc.
- Urea compounds as activators of potassium channels kv7.2/7.3 useful in the treatment of cns and pns disorders23 Jul 2026US 2026/0207563 A1Angelini Pharma S.P.A.
Most cited
By later US patents
- Heterocyclic compounds useful as inhibitors of tyrosine kinases202US 6,506,769 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2003
- Heterocyclic compounds useful as inhibitors of tyrosine kinases190US 6,770,639 B2Boehringer Ingelheim Pharmaceuticals, Inc. · 2004
- Isoquinolinone derivatives and their use as therapeutic agents148US 7,265,131 B2Exelixis, Inc. · 2007
- Substituted phenethylsulfones and method of reducing TNF.alpha. levels136US 6,020,358 ACelgene Corporation · 2000
- Compounds for inhibition of ceramide-mediated signal transduction117US 6,323,201 B1The Regents of the University of California · 2001